However, this could be due to the participants having already established S protein-specific CD8+ T cell responses from COVID-19 vaccination, which will then be favored upon antigen re-exposure, especially considering the degree of conservation of CD8+ T cell epitopes between the SARS-CoV-2 variants. Here, CD8A is linked to COVID-19.